Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 0.22 is 63% below its 5-year average of 0.61, near the low end of its 5-year range (0.00–1.41).
As of the fiscal period ended Tuesday, June 30, 2026. 67.35% below its 12-month average of 0.69.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.22.
QUICK RATIO (ACID-TEST)
0.22
QUICK RATIO (ACID-TEST) AVG TTM
0.69
QUICK RATIO (ACID-TEST) AVG 3Y
0.72
QUICK RATIO (ACID-TEST) AVG 5Y
0.61
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-67.35%
CURRENT VS 3Y AVG
-68.92%
CURRENT VS 5Y AVG
-63.21%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.83
median of 454 covered companies
CURRENT VS SECTOR MEDIAN
-92.06%
vs the sector median at left
Akanda Corp.
Market Cap
$61819.00
Quick Ratio (Acid-Test)
0.22
TTM Avg
0.69
3Y Avg
0.72
5Y Avg
0.61
Market Cap
$570131.00
Quick Ratio (Acid-Test)
0.06
TTM Avg
0.15
3Y Avg
3.02
5Y Avg
6.94
Market Cap
$707297.00
Quick Ratio (Acid-Test)
1.49
TTM Avg
0.81
3Y Avg
1.60
5Y Avg
1.33
Market Cap
$787624.00
Quick Ratio (Acid-Test)
4.64
TTM Avg
5.46
3Y Avg
4.98
5Y Avg
8.82
Market Cap
$878396.00
Quick Ratio (Acid-Test)
8.67
TTM Avg
12.04
3Y Avg
7.97
5Y Avg
19.74
Market Cap
$885939.00
Quick Ratio (Acid-Test)
0.46
TTM Avg
3.06
3Y Avg
2.92
5Y Avg
4.33
Market Cap
$888387.00
Quick Ratio (Acid-Test)
1.83
TTM Avg
2.05
3Y Avg
3.13
5Y Avg
5.42
Market Cap
$1.02M
Quick Ratio (Acid-Test)
7.81
TTM Avg
0.12
3Y Avg
1.01
5Y Avg
1.01
Market Cap
$1.11M
Quick Ratio (Acid-Test)
4.31
TTM Avg
1.47
3Y Avg
1.08
5Y Avg
7.17
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Akanda Corp. (AKAN) | $61819.00 | 0.22 | 0.69 | 0.72 | 0.61 |
| HCW Biologics Inc. (HCWB)vs › | $570131.00 | 0.06 | 0.15 | 3.02 | 6.94 |
| CDT Equity Inc. (CDT)vs › | $707297.00 | 1.49 | 0.81 | 1.60 | 1.33 |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $787624.00 | 4.64 | 5.46 | 4.98 | 8.82 |
| Bone Biologics Corporation (BBLG)vs › | $878396.00 | 8.67 | 12.04 | 7.97 | 19.74 |
| GlucoTrack, Inc. (GCTK)vs › | $885939.00 | 0.46 | 3.06 | 2.92 | 4.33 |
| Decoy Therapeutics Inc. (DCOY)vs › | $888387.00 | 1.83 | 2.05 | 3.13 | 5.42 |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.02M | 7.81 | 0.12 | 1.01 | 1.01 |
| Clearmind Medicine Inc. (CMND)vs › | $1.11M | 4.31 | 1.47 | 1.08 | 7.17 |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.14M | 3.75 | 3.27 | 2.43 | 2.43 |
Quick Ratio
0.22
Excludes inventory
Current Ratio
0.22
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 0.22 |
| 2025-12-31 | 0.58 |
| 2025-06-30 | 1.25 |
| 2024-12-31 | 1.39 |
| 2024-06-30 | 1.41 |
| 2023-12-31 | 0.05 |
| 2023-06-30 | 0.14 |
| 2022-12-31 | 0.21 |
| 2022-06-30 | 0.96 |
| 2021-12-31 | 0.48 |
| 2021-06-30 | 0.00 |
| 2020-12-31 | 0.05 |
| 2020-06-30 | 0.00 |
| 2019-12-31 | 0.00 |
| 2019-06-30 | 0.00 |
